Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis (IPF) and made the case for further development of its potentially disease-modifying ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
CEO D. Bidzos reported that VeriSign delivered growth in both its domain name base and financial performance during the third quarter, highlighting continued "return of value to shareholders through ...
Introduction: There is a need for biomarkers predicting neurocognitive improvement following treatment of obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP). The role of ...
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced positive topline results from the registrational Phase 1/2 STAAR study ...
There is a new AI generated appraisal tool at OceanFrontDomains.com. Rick commented on X “Howard Fellman has unveiled his new ai generated domain appraisal tool and it is fantastic!!” “Now, when some ...
There is a new AI generated appraisal tool at OceanFrontDomains.com. Rick commented on X “Howard Fellman has unveiled his new ai generated domain appraisal tool and it is fantastic!!” “Hmmm ...
MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation (Humanetics) announced today the results of its Phase 2 clinical trial of BIO 300 Oral Suspension (BIO 300) for the mitigation of impaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results